Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. (NASDAQ: HSIC) generates a steady flow of news as a FORTUNE 500 and S&P 500® health care solutions company serving office-based dental and medical practitioners. As a medical, dental, and hospital equipment and supplies merchant wholesaler with a significant technology footprint, the company issues updates that cover financial performance, leadership changes, partnerships, and product and technology developments.
Investors following HSIC news will find regular earnings and guidance announcements, including quarterly financial results and updates on sales growth across its Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. These releases often highlight trends in dental and medical distribution, specialty dental products, and technology adoption, as well as commentary on strategic initiatives such as the company’s BOLD+1 strategy and value creation programs.
Henry Schein news also includes leadership and governance updates, such as the announced retirement of long-time CEO Stanley M. Bergman from the chief executive role and the appointment of Frederick M. Lowery as the company’s next CEO, effective March 2, 2026. These items provide insight into succession planning and the company’s approach to long-term leadership continuity.
Another key theme in HSIC coverage is technology and innovation in dental practice management. Through Henry Schein One, the company reports on new AI-enabled workflows, embedded automation, and collaborations with partners like Amazon Web Services and VideaHealth. News items describe developments in practice management platforms such as Dentrix and Dentrix Ascend, including AI-driven documentation, imaging, and revenue cycle tools.
In addition, Henry Schein announces strategic partnerships and distribution agreements, such as its expanded relationship with vVARDIS for the Curodont Repair Fluoride Plus product across U.S. dental segments. These stories shed light on how the company broadens its product offerings and supports dental professionals with new clinical options.
For investors, analysts, and health care professionals, the HSIC news feed on Stock Titan offers a centralized view of these corporate developments, helping users monitor how Henry Schein’s distribution, specialty products, and technology initiatives evolve over time.
Henry Schein, the leading provider of health care solutions, has promoted Jennifer Ferrero to Vice President, Senior Counsel and Corporate Secretary, effective July 1, 2022. Ms. Ferrero has been with the company since 2004, previously serving as Vice President, Senior Counsel, Corporate & Deputy Secretary. In her new role, she will oversee corporate governance and board activities. CEO Stanley M. Bergman commended her for her leadership and expertise, particularly in Environmental, Social & Governance (ESG) matters.
Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in the Piper Sandler Dental Investor Day on March 29, 2022, at 9:00 a.m. Eastern time. Investors can access the live webcast on the company's website, with a replay available afterward. Headquartered in Melville, N.Y., Henry Schein serves over 1 million customers globally, reporting sales of $12.4 billion in 2021. The company is a member of the S&P 500 and has a broad product portfolio and a network of over 21,600 employees.
Henry Schein has been recognized as one of the 2022 World’s Most Ethical Companies by Ethisphere for the 11th consecutive year, being the only honoree in the Healthcare Products industry. The recognition highlights the company’s commitment to ethical practices, aligning with its philosophy of ‘doing good’ to achieve business success. The Ethics Index shows that honorees outperformed a comparable index by 24.6 percentage points over five years, emphasizing the financial benefits of ethical governance.
Henry Schein (NASDAQ: HSIC) announces its role as a founding sponsor of Women in DSO®, supporting the inaugural event ‘Empower and Grow 2022’ from March 9-11, 2022, in Las Vegas. The company will sponsor keynote speaker Bonnie St. John, a renowned Paralympic medalist. This initiative reflects Henry Schein’s commitment to enhancing female leadership in the dental industry, providing mentorship, networking opportunities, and resources through their Women's Leadership Network.
Henry Schein, Inc. (NASDAQ: HSIC) showcased a diverse array of products and services at the 2022 Chicago Midwinter Dental Meeting, emphasizing advancements in dental practice performance. Key highlights included the launch of the Medit i700 intraoral scanner and Septodont BioRoot Flow root canal sealer. The company also introduced Jarvis for Private Practices, enhancing practice analytics. Visitors engaged with leaders from multiple renowned dental product companies while exploring solutions aimed at optimizing workflow efficiency. The meeting, held from February 24-26, 2022, provided a platform for networking and learning innovations in oral health.
Henry Schein, Inc. (NASDAQ: HSIC) has launched a virtual program titled “Optimism and Opportunities in Oral Health,” coinciding with the Chicago Midwinter Dental Meeting. This on-demand program features discussions with ASDA leaders and Henry Schein executives, focusing on the dental profession's evolution. CEO Stanley Bergman emphasized the importance of sharing insights for the advancement of dentistry. This initiative reflects the company's commitment to oral health as part of overall healthcare.
Zahn Dental, the dental laboratory business of Henry Schein, has committed $150,000 to Feeding America to aid communities facing food insecurity, particularly seniors. This contribution aims to enhance access to nutrition and combat malnutrition among elderly individuals, who often suffer from chronic conditions affecting their dietary needs. Zahn's supplier partners will also support this initiative. Feeding America highlights that over 38 million people in the U.S. face food insecurity, an issue worsened by the pandemic. This partnership aligns with Zahn's mission to link oral health with overall well-being.
Henry Schein reported fourth-quarter 2021 net sales of $3.3 billion, a 5.2% increase year-over-year. GAAP diluted EPS from continuing operations rose to $1.05, up from $0.99 a year earlier. Non-GAAP diluted EPS also increased to $1.07 from $1.00.
The company projects 2022 GAAP diluted EPS between $4.75 and $4.91, reflecting 7% to 10% growth from 2021. Global dental sales reached $2.0 billion for the quarter, a 9.4% rise, while medical sales declined by 3.2%. The company continues to focus on operational improvements and technology services.
Summary not available.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in two virtual investor events in February 2022. The events include the Baird 2022 Sustainability Conference on February 23, 2022, at 2:20 p.m. Eastern and the Jefferies 2022 Dental Summit on February 24, 2022, at 1:00 p.m. Eastern. The Baird conference will be available for live webcast, with replays accessible on their website. Henry Schein reported $10.1 billion in sales for 2020, highlighting its significant impact in the healthcare industry.